Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758327/
https://www.ncbi.nlm.nih.gov/pubmed/26949713
http://dx.doi.org/10.1093/ofid/ofv183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758327/
https://www.ncbi.nlm.nih.gov/pubmed/26949713
http://dx.doi.org/10.1093/ofid/ofv183

Ejemplares similares